Sinclair Pharma acquires Refine ’ s breast-lifting tech for $11m

Sinclair Pharma today acquired the rights to cosmetic device developer Refine Medical’s Refine Support System breast lifting technology for $11.3 million. The Refine Support System is a soft and flexible suture-mesh-anchor system designed to lift and support tissue, according to London-based Sinclair Pharma. The company said that the system can be used for a variety of different cosmetic or reconstructive tissue procedures, including standalone procedures or to enhance other cosmetic or reconstructive procedures. “Over the last several years I have had the opportunity to treat over 150 patients with the Refine Support system as we have developed the product and techniques.  I have found Refine to be highly beneficial in both my breast lift and breast reduction procedures, providing a means to achieve and maintain upper pole fullness that I find to be unobtainable without Refine.  The technique learning curve is short and we have had minimal adverse events. My patients are very active and routinely engage in sports and aerobic workouts without any limitations.  It would be very hard to imagine no longer having the Refine Support system in my armamentarium given the results and patient satisfaction we are achieving; results that we cannot obtain in any other way,”  Dr Bruce Van Natta of Indianapolis’ Indiana University Medical Center said in a prepared statement. Sinclair said that Refine system will be incorporated into its Silhouette portfolio. The R...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Cosmetic/Aesthetic Mergers & Acquisitions refinemedical sinclairpharma Source Type: news